ABSTRACT
INTRODUCTION Non-Hodgkin's lymphomas (NHL) are a diverse group of diseases. They are the fifth most common cancers in the U.S. with 55,000 new cases diagnosed each year. The incidence has increased since the 1970s by approximately 3% each year [1,2].
